Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.595 USD | -0.68% | -1.42% | +6.54% |
04-19 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
04-01 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
Sales 2024 * | 126M 10.07B | Sales 2025 * | 145M 11.6B | Capitalization | 201M 16.07B |
---|---|---|---|---|---|
Net income 2024 * | 6M 479M | Net income 2025 * | 18M 1.44B | EV / Sales 2024 * | 1.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.39 x |
P/E ratio 2024 * |
30
x | P/E ratio 2025 * |
11.4
x | Employees | 459 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.35% |
Latest transcript on Lifecore Biomedical, Inc.
1 day | -0.68% | ||
1 week | -1.42% | ||
Current month | +24.20% | ||
1 month | +24.20% | ||
3 months | -0.68% | ||
6 months | -6.19% | ||
Current year | +6.54% |
Managers | Title | Age | Since |
---|---|---|---|
James Hall
CEO | Chief Executive Officer | 61 | 31/05/17 |
John Morberg
DFI | Director of Finance/CFO | 60 | 17/01/21 |
Steve Laninga
COO | Chief Operating Officer | - | 31/12/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nelson Obus
BRD | Director/Board Member | 77 | 11/10/18 |
Jeffrey Edwards
BRD | Director/Board Member | 64 | 13/10/20 |
Katrina Houde
BRD | Director/Board Member | 66 | 04/08/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +6.26% | - | |
0.00% | 147 M€ | +4.88% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 6.595 | -0.68% | 110,906 |
25/04/24 | 6.64 | +4.90% | 256,407 |
24/04/24 | 6.33 | -1.86% | 105,089 |
23/04/24 | 6.45 | +2.54% | 136,987 |
22/04/24 | 6.29 | -5.98% | 169,821 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.54% | 201M | |
+25.83% | 661B | |
+26.17% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.56% | 231B | |
+5.28% | 200B | |
-9.04% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- LFCR Stock